PointFinder

PointFinder predicts species-specific chromosomal mutations associated with drug resistance from whole genome sequencing (WGS) data in Mycobacterium tuberculosis.

Key Features:

• Comprehensive Mutation Analysis: Detects and reports insertions, deletions, frameshift mutations, and premature stop codons from WGS-derived genomic sequences.
• Premature Stop Codon Detection: Identifies over-representation of premature stop codons in resistance-associated genes katG, ethA, pncA, and gidB to enhance resistance prediction.
• Optimized Mutation Library: Uses forward feature selection to remove non-predictive lineage markers and refine the mutation library for improved predictive accuracy.
• Integration with ResFinder: Combines chromosomal mutation detection with ResFinder's identification of acquired resistance genes for comprehensive resistance profiling.

Scientific Applications:

• Drug resistance prediction: Infers genetic determinants of antimicrobial resistance in Mycobacterium tuberculosis from WGS data.
• Clinical diagnostics: Supports interpretation of genomic markers to inform treatment decisions for tuberculosis patients.
• Epidemiological surveillance: Enables analysis of resistance-associated mutations for population-level studies of resistance emergence and spread.

Methodology:

Analyzes WGS data to detect species-specific chromosomal mutations, explicitly identifies insertions, deletions, frameshifts, and premature stop codons, refines the mutation library using forward feature selection to exclude non-predictive lineage markers, and integrates with ResFinder to detect acquired resistance genes.